Reichman University in Herzliya will host Le’Maanchem’s annual medical-innovation conference on November 10, bringing together over 800 experts to explore how stem-cell medicine and AI are transforming healthcare.
President Isaac Herzog is slated to open the event with greetings, underscoring the national profile of a gathering that organizers say will spotlight breakthrough work in regenerative medicine, organ and tissue repair, and AI-guided, patient-specific care. The conference, now in its third year, is being held in partnership with Reichman University and is closed to invited guests.
Among the slated speakers are Prof. Uriel Reichman, Reichman University’s founding president and board chair; Prof. Ran Balicer of Clalit; Maj.-Gen. (res.) Yohanan Locker, chairman of Clalit Health Services; Prof. Jacob Hanna of the Weizmann Institute of Science; Prof. Eran Meshorer of the Hebrew University; Prof. Ayal Hendel of Bar-Ilan University; and Prof. Irit Avivi, head of the hematology division at Tel Aviv Sourasky Medical Center (Ichilov). Television presenter and actor Guy Zu-Aretz will host.
A central leadership panel will discuss how to embed AI in decision-making across Israel’s hospitals and health funds while preserving the human touch in care. According to the organizers, participants include Dr. Eitan Wertheim, CEO of Clalit Health Services; Dr. Michal Mekel, director of Rambam Health Care Campus; Prof. Eli Sprecher, director general of Tel Aviv Sourasky Medical Center; Prof. Orly Weinstein, CEO of Sheba Negev; and Sigal Dadon-Levi, CEO of Maccabi Health Services. Their current roles have been confirmed in recent official announcements and institutional profiles.
Sigal Dadon-Levi said ahead of the conference that “the AI revolution is not a future vision, it is already here, transforming how we diagnose, treat, and prevent disease. At Maccabi, we are leading dozens of innovative AI projects in medicine, research, and service, as part of our organizational strategy. Our vision is to provide Maccabi members with truly personalized medicine, more precisely matched to each patient’s needs and characteristics.”
Prof. Avivi will outline how AI is expected to accelerate testing, speed drug development, and tailor therapies at the individual level. “It may look like science fiction today, but within a decade at most, AI is likely to become a routine part of physicians’ work and improve accuracy, efficiency, and clinical outcomes,” she said.
The program will also feature a one-on-one conversation between Prof. Balicer and Israel Prize laureate Gil Shwed, the Check Point founder and executive chairman, about the boundary between medical innovation and high-tech and the limits of AI in care.
Beyond the science and policy, the conference will include a recognition ceremony for physicians and volunteers who served IDF soldiers and the Israeli public during the Iron Swords war, reflecting Le’Maanchem’s broader mission of volunteer-based medical guidance for thousands of patients across Israel.
Le’Maanchem founder and chair Yossi Arbelich established the conference to convene clinical leaders and technologists around practical advances. At the same time, the organization’s president, Prof. Joseph Press, and innovation head, Dr. Gadi Neuman, help steer its medical agenda with academic partners at Reichman University.